Skip to content

Hemoglobin Microcuvettes

by Hangzhou Bosure Biotech Co., Ltd

Ref BA-201-1Model BS-201

Hemoglobin Microcuvettes (BA-201-1) is an in vitro diagnostic device (EU IVDR Class A; EMDN category samples transport) made by Hangzhou Bosure Biotech Co., Ltd, registered in EUDAMED on 17 Jun 2025 (Basic UDI-DI 6975519630028A69), active as of 23 Oct 2026.

Active European Union

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number6975519630028A69 Basic UDI-DI 06975519631196UDI-DIDate17 Jun 2025RegisteredStatusActive

Official records

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDR Active

Specification

EUDAMED

Device name
Hemoglobin Microcuvettes
Model / reference
BS-201, BA-201-1
Primary DI / UDI-DI
06975519631196
Basic UDI-DI
6975519630028A69
EMDN code
W05020199 Samples transport, containers - other
Device class
Class A
EU registration type
Standard device
EU market of registration
France

Manufacturer details

EUDAMED SRN
CN-MF-000003001
Authorised representative
JOYSUN GROUP S.L.U ES-AR-000043666

Similar devices in this category

Other devices filed under SAMPLES TRANSPORT, CONTAINERS - OTHER.

Other devices from Hangzhou Bosure Biotech Co., Ltd

See all devices from Hangzhou Bosure Biotech Co., Ltd →

Properties

  • Near-patient testing
  • Professional testing
  • New device
Other properties (10, all answered No)